Want to join the conversation?
$A's R&D expenses decreased 8% in 3Q15 primarily due to the impact of favorable foreign currency movements and savings from the exit from NMR business, offset by wage increases. $A also confirmed that it will no longer report orders in its periodic filings with the SEC or its quarterly earnings press release starting in 4Q15.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.